Photo by nci from unsplash
The study conducted by Kirchhof et al. [(1)][1] showed low bleeding and stroke rates in rivaroxaban-treated patients with atrial fibrillation (AF). We would emphasize the potential bias of including more low-risk… Click to show full abstract
The study conducted by Kirchhof et al. [(1)][1] showed low bleeding and stroke rates in rivaroxaban-treated patients with atrial fibrillation (AF). We would emphasize the potential bias of including more low-risk patients in real-world studies, because current guidelines neglect the causal
Keywords:
atrial fibrillation;
real world;
world studies;
potential bias
Journal Title: Journal of the American College of Cardiology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!